Drugs · Entity Annotation Prototype (beta)

7articles mentioning drugs

24drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: BsAb ×

BsAb

This drug is selected. Its supporting articles are shown below.

BsAb7

Articles mentioning BsAb

7 articles · page 1 of 1

703 Cross-help between mAb-activated NK cells and bsAb-activated T cells

jitc · abstract · 2025-11-04 · 10 matching annotations

91.2%

bsAb bsAbs anti-CD38 mAb bsAb-mediated bsAb-activated

…nd T cells results in enhanced target cell killing when mAb and bsAb are given together. These data provide further support for eval…

Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma

jitc · abstract · 2026-03-06 · 7 matching annotations

92.2%

BsAb BsAbs multiple myeloma six academic institutions MM

… microbiota-preserving strategies could enhance the efficacy of BsAb therapy in MM.…

977 The discovery and development of a cyno cross-reactive CD3 VHH antibody platform to optimize the development of T cell engagers for oncology and autoimmune diseases

jitc · abstract · 2025-11-04 · 3 matching annotations

91.1%

TCE bsAb bsAbs HER2 BCMA

…ivo, thereby validating these CD3 VHHs as an ideal platform for TCE engineering.…

Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol

bmjopen · abstract · 2026-05-07 · 1 matching annotations

78.6%

BsAb lymphoma myeloma

…s six Australian centres enrolling adults treated with CAR-T or BsAb therapies. A co-designed REDCap (Research Electronic Data Captu…

1103 Semi-mechanistic PK modeling of bispecific antibodies for optimal dose prediction: a clinically confirmable and AI-expandable framework using bell-shaped PD responses

jitc · abstract · 2025-11-04 · 1 matching annotations

77.4%

bispecific antibodies bsAbs bsAb

…odynamic data to predict human PK and inform dose selection for bispecific antibodies. The approach serves as a viable alternative to animal testing,…

439 A novel humanized mouse model for preclinical efficacy evaluation of anti-CD47/anti-SIRPα therapeutics

jitc · abstract · 2025-11-04 · 1 matching annotations

77.3%

Magrolimab BsAb GemPharmatech

… was used to assess anti-tumor efficacy of anti-hCD47 antibody (Magrolimab (5F9)) in a CT26-hCD47 (CT26 cells overexpressing human CD47) c…

987 Next-generation platform for high-throughput production of true four-chain bispecific antibodies

jitc · abstract · 2025-11-04 · 1 matching annotations

81.6%

bsAbs bsAb HCCF

…PLC, Intact Mass analysis, and LAL assays.Results A total of 30 bsAbs were successfully produced in both double-tagged and non-tagged…

Browse drugs

BsAb

Articles mentioning BsAb

703 Cross-help between mAb-activated NK cells and bsAb-activated T cells

Antibiotic-associated dysbiosis and bispecific antibody outcomes in multiple myeloma

977 The discovery and development of a cyno cross-reactive CD3 VHH antibody platform to optimize the development of T cell engagers for oncology and autoimmune diseases

Longitudinal real-world surveillance of infection outcomes in CAR-T and bispecific therapy recipients: the CLARITY study protocol

1103 Semi-mechanistic PK modeling of bispecific antibodies for optimal dose prediction: a clinically confirmable and AI-expandable framework using bell-shaped PD responses

439 A novel humanized mouse model for preclinical efficacy evaluation of anti-CD47/anti-SIRPα therapeutics

987 Next-generation platform for high-throughput production of true four-chain bispecific antibodies